Binding characteristics of cetirizine and levocetirizine to human H(1) histamine receptors: contribution of Lys(191) and Thr(194).
about
Structure of the human histamine H1 receptor complex with doxepinPharmacology of antihistaminesCrystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptorInternational Union of Basic and Clinical Pharmacology. XCVIII. Histamine ReceptorsMolecular determinants of ligand binding at the human histamine H1 receptor: Site-directed mutagenesis results analyzed with ligand docking and molecular dynamics studies at H1 homology and crystal structure modelsSynthesis of aryl-substituted naphthalene-linked pyrrolobenzodiazepine conjugates as potential anticancer agents with apoptosis-inducing ability.Pharmacology of antihistamines.Interaction of active compounds from Aegle marmelos CORREA with histamine-1 receptorTwenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skinGPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1-2 September 2014.Comparison of levocetirizine pharmacokinetics after single doses of levocetirizine oral solution and cetirizine dry syrup in healthy Japanese male subjects.Allergic rhinitis in family practice: the role of levocetirizine in clinical care.Therapeutic management of allergic diseases.Drug metabolism and pharmacokinetics.Pharmacokinetics in special populations.From pharmacokinetics to therapeutics.Clinical evaluation and treatment of chronic urticaria.Positron emission tomography evaluation of sedative properties of antihistamines.Pharmacokinetic evaluation of levocetirizine.H(1)-antihistamines and urticaria: how can we predict the best drug for our patient?Synthesis and characterization of a disubstituted piperazine derivative with T-type channel blocking action and analgesic properties.A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites.Induction of prolonged, continuous slow-wave sleep by blocking cerebral H₁ histamine receptors in rats.Pharmacological profile of astemizole-derived compounds at the histamine H1 and H4 receptor--H1/H4 receptor selectivity.The Target Residence Time of Antihistamines Determines Their Antagonism of the G Protein-Coupled Histamine H1 Receptor.Peripheral and central H1 histamine receptor occupancy by levocetirizine, a non-sedating antihistamine; a time course study in the guinea pig.Levocetirizine: the allergist's arsenal grows larger.Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial.Fixed drug eruption: a novel side-effect of levocetirizine.Attenuation of histamine-induced airway effects by intranasal application of levocetirizine in mice.Linking agonist binding to histamine H1 receptor activation.A simulated car-driving study on the effects of acute administration of levocetirizine, fexofenadine, and diphenhydramine in healthy Japanese volunteers.Brain histamine H1 receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine.Use of the harmonic mean to the determination of dissociation constants of stereoisomeric mixtures of biologically active compounds.Effects of levocetirizine and diphenhydramine on regional glucose metabolic changes and hemodynamic responses in the human prefrontal cortex during cognitive tasks.Cetirizine in horses: pharmacokinetics and effect of ivermectin pretreatment.Application of Guanidine Hcl to Improve Enantioseparation of a Model Basic Drug, Cetirizine, By Capillary Electrophoresis Using Sulfated Β-Cyclodextrin.Pharmacology of AntihistaminesEnantioselective disposition of clenbuterol in rats
P2860
Q24595968-37FB6881-A353-49B3-95E6-DF662D2CABB0Q24618798-FCA52594-A206-47AC-878D-ED100E546922Q24633082-DD846847-8C22-4BA2-B856-F486092A71A4Q26827568-068C9C1E-6F18-4874-ABBA-A37320A8D60AQ33858991-26E98727-151E-4606-A8E5-CD7BA6044E6BQ33952790-1A844FB1-0599-4786-B966-E4889550E4E9Q34347782-0BB31590-0EC8-4B68-AD2F-80E6F10291BCQ34764004-B27D3520-93A0-4D62-9B44-6B7817CF410FQ35825734-7DC620BC-ED8B-4141-9C77-E6019943D60FQ35830953-7B35A182-9DED-4F0E-A01F-9B945DA0581DQ37077139-2B8CCBCC-4565-4FA2-9FB1-EE1A4484B8A5Q37226409-24340B6A-CB91-4033-B53A-FDAF198183BBQ37550543-6EAE9CB0-B093-46ED-A4B0-22C6541B5BDDQ37550548-8BCA0961-0B8A-4BBA-9B7E-556F136E465BQ37550561-DA8EE0A9-157F-424B-B538-97AA740AD827Q37550564-ADABFF7D-AFF4-47F6-AD37-6B2EEBF2B74AQ37702745-CDDB4BC5-EE89-4FD3-8E6A-002881664975Q37869149-A1CBA8C6-3C9D-4698-8A3D-B3F55932EC49Q37884622-B2A6C431-EE5F-4231-85D7-5AC6126B4B1CQ38044949-3D802E27-0202-4219-8AA1-9F0E6BBDE0C4Q39174362-C7CEF80E-7645-41D0-81EE-979BF25C41E3Q39411714-3BB385ED-7119-45D9-B168-27A0CFD00B76Q40174344-DD2DA131-3E7E-4938-AD8F-9CAD30FE94BFQ40218158-8C209ADC-EACE-4748-B2A0-6DC07BF7EDD3Q42005919-6956F697-B581-4643-892F-AD9B31DEABFEQ42369933-F220EE3C-C78F-412E-B7AE-316E7B91AB66Q42626124-03A09821-8B14-4ED7-A09E-29AFCA383AE9Q44948343-73A6E08B-D8ED-4693-8169-0C0AB28884E2Q46457421-C9D0D566-781A-4D8D-90A3-EE501F9BD071Q46680640-F771FC35-6DFF-4F31-96B8-645DA3E715FEQ46872039-D5E41FB1-1B7D-497B-A1AE-92D65FBAD601Q46890983-5B004BFD-F236-401E-8634-4C83CCEEDDABQ47450319-411E26C2-D629-4B73-8FF7-376B1CB50270Q48010806-B3FE4176-A540-4A0B-8B0C-611CFAAEE8ABQ51112892-B2C3BDC2-DFC4-4CDE-9761-321EEDCBE801Q52658852-B112E3B4-198A-44B5-B787-66088C22D972Q52679436-51DD543B-E628-4AC3-A97E-E61885A716CBQ55235241-A36A7EDF-ADBC-4B69-BBBB-613C5017A7B4Q56536196-7A661CA1-9A35-4118-BD64-9FF8D1F81B75Q57152532-5C18F24A-43F1-4FF8-AC84-96B3EB1D7178
P2860
Binding characteristics of cetirizine and levocetirizine to human H(1) histamine receptors: contribution of Lys(191) and Thr(194).
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Binding characteristics of cet ...... tion of Lys(191) and Thr(194).
@ast
Binding characteristics of cet ...... tion of Lys(191) and Thr(194).
@en
type
label
Binding characteristics of cet ...... tion of Lys(191) and Thr(194).
@ast
Binding characteristics of cet ...... tion of Lys(191) and Thr(194).
@en
prefLabel
Binding characteristics of cet ...... tion of Lys(191) and Thr(194).
@ast
Binding characteristics of cet ...... tion of Lys(191) and Thr(194).
@en
P2093
P356
P1476
Binding characteristics of cet ...... tion of Lys(191) and Thr(194).
@en
P2093
Christy Van Der Perren
Michel Gillard
Pierre Chatelain
Roy Massingham
P304
P356
10.1124/MOL.61.2.391
P577
2002-02-01T00:00:00Z